New research sets out to help children suffering from Attention Deficit Hyperactivity Disorder

September 02, 2002

Researchers from Imperial College London have today been granted an award of £221,700 to study ADHD (Attention Deficit Hyperactivity Disorder) by Cerebra, the foundation for the brain-injured infant.

ADHD is a behavioural condition affecting up to fifteen percent of children in the UK. Symptoms include poor attention span, weak impulse control and hyperactivity

Lead researcher, Professor John Gruzelier from Imperial College London at the Charing Cross hospital says: "Research from America has shown that although manageable in up to sixty percent of children, ADHD is not curable, and up to seventy percent of children fail to outgrow it. Medication is available, but is only effective in less than half of all cases. This, combined with significant side effects, such as loss of appetite, headaches, sleeping problems, mood problems and growth reduction, means there is an urgent need for a more effective treatment."

The study will examine whether a therapy known as EEG biofeedback, or neurofeedback, can help to treat children suffering from ADHD. Neurofeedback is a process that will allow children to view their brain activity on a computer. Changes in cortical activity are fed back to the child in the form of visual and auditory images.

Research has shown that children with ADHD exhibit excess slow wave (4-8Hz) activity and reduced fast wave (12-20Hz) activity. The aim will be to correct this imbalance by training children to decrease slow wave activity and where appropriate increase the fast wave activity.

Professor Gruzelier adds: "As a treatment for ADHD, Neurofeedback has the potential to provide long term benefits in cognition and behaviour. Importantly it is non-invasive, has no known side effects and if proven successful may reduce dependency on Ritalin."

David Williams, Head of Research at Cerebra adds: "We are extremely pleased to be able to fund this project. Imperial are acknowledged leaders in this field, and this research will benefit the large numbers of children suffering from Attention Deficit Hyperactivity Disorder."
For more information, please contact:

Tony Stephenson
Imperial College Press Office
Tel: +44 (0)20 7594 6712
Mobile: +44 07753 739766

Notes to editors: 1. 1. Consistently rated in the top three UK university institutions, Imperial College London is a world leading science-based university whose reputation for excellence in teaching and research attracts students (10,000) and staff (5,000) of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and management and delivers practical solutions that enhance the quality of life and the environment - underpinned by a dynamic enterprise culture. Website:
2. Cerebra is a national charity with an administrative headquarters in Carmarthen West Wales, telephone 01267-244200 and a fund raising call centre based in Bristol.
3. Cerebra is concerned with brain injury in children. The charity raises money to fund ground breaking research into brain injury and neurological disorders, cerebral palsy, attention deficit disorder, behavioural and emotional problems or developmental delay in infants.
4. Cerebra also acts as a catalyst to provide interaction between professional research and the insight of parents and carers. Cerebra have a specialist information base built up over ten years and ensure that information flows productively between researchers and parents, with all feedback disseminated effectively to produce real outcomes on the ground for affected families and their children.

Imperial College London

Related ADHD Articles from Brightsurf:

Autism and ADHD share genes
Researchers from the national psychiatric project iPSYCH have found that autism and ADHD share changes in the same genes.

ADHD across racial/ethnic groups
This study of patients from diverse racial/ethnic backgrounds who received care at the Kaiser Permanente Northern California health system looked at how common attention-deficit/hyperactivity disorder (ADHD) diagnoses were over a 10-year period across seven racial/ethnic groups.

Cycles of reward: New insight into ADHD treatment
Researchers at the Okinawa Institute of Science and Technology Graduate University (OIST) in collaboration with scientists at the University of Otago and the University of Auckland in New Zealand, investigated the actions of the drug in rats.

Young mums more likely to have kids with ADHD
Young mothers have a greater chance of having a child with attention deficit hyperactivity disorder (ADHD) according to new research from the University of South Australia.

ADHD medication: How much is too much for a hyperactive child?
When children with ADHD don't respond well to Methylphenidate (MPH, also known as Ritalin) doctors often increase the dose.

Antipsychotic use in youths with ADHD is low, but still cause for concern
A new study eased fears about the proportion of youths with ADHD taking antipsychotic drugs, but still found that many prescriptions may be inappropriate.

How stimulant treatment prevents serious outcomes of ADHD
Analysis quantifies the extent which stimulant treatment reduces serious outcomes in children and young adults with ADHD.

Did Leonardo da Vinci have ADHD?
Leonardo da Vinci produced some of the world's most iconic art, but historical accounts show that he struggled to complete his works.

More sleep may help teens with ADHD focus and organize
Teenagers with attention deficit hyperactivity disorder (ADHD) may benefit from more sleep to help them focus, plan and control their emotions.

Researchers have found the first risk genes for ADHD
A major international collaboration headed by researchers from the Danish iPSYCH project, the Broad Institute of Harvard and MIT, Massachusetts General Hospital, SUNY Upstate Medical University, and the Psychiatric Genomics Consortium has for the first time identified genetic variants which increase the risk of ADHD.

Read More: ADHD News and ADHD Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to